Ignite Creation Date:
2024-05-06 @ 9:07 AM
Last Modification Date:
2024-10-26 @ 12:10 PM
Study NCT ID:
NCT02906202
Status:
COMPLETED
Last Update Posted:
2023-06-18
First Post:
2016-08-19
Brief Title:
A Study Evaluating the Efficacy and Safety of the LentiGlobin BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia Who do Not Have a β0β0 Genotype
Sponsor:
bluebird bio
Organization:
bluebird bio
Organization Data
Organization:
bluebird bio
Class:
INDUSTRY
Study ID:
HGB-207
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
bluebird bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None